Improvement of some pharmaceutical properties of DY-9760e by sulfobutyl ether β-cyclodextrin

International Journal of Pharmaceutics

Volumn 229, Issue 1-2, 2001, Pages 163-172

  Nagase, Y ^a   Hirata, M ^b   Wada, K ^b   Arima, H ^b   Hirayama, F ^b   Irie, T ^b   Kikuchi, M ^a   Uekama, K ^b  

^a DAIICHI SANKYO CO   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

Author keywords

2 Hydroxypropyl cyclodextrin; Adsorption; DY 9760e; Inclusion complexation; Photo stability; Solubility; Sulfobutyl ether cyclodextrin

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; 3 [2 [4 (3 CHLORO 2 METHYLPHENYL) 1 PIPERAZINYL]ETHYL] 5,6 DIMETHOXY 1 (4 IMIDAZOLYLMETHYL) 1H INDAZOLE; BENZENE; BETA CYCLODEXTRIN SULFOBUTYL ETHER; BUFFER; DY 9760E; INDAZOLE DERIVATIVE; PIPERAZINE; POLYVINYLCHLORIDE; UNCLASSIFIED DRUG;

AQUEOUS SOLUTION; ARTICLE; CHEMICAL STRUCTURE; CIRCULAR DICHROISM; DRUG ADSORPTION; DRUG POTENTIATION; DRUG SOLUBILITY; DRUG STABILITY; DRUG SYNTHESIS; ELECTRICITY; HYDROPHOBICITY; INCUBATION TIME; IONIC STRENGTH; MOLECULAR INTERACTION; NUCLEAR MAGNETIC RESONANCE; PH; PHOTODEGRADATION; PRIORITY JOURNAL; SPECTROSCOPY;

ADSORPTION; BETA-CYCLODEXTRINS; CIRCULAR DICHROISM; CYCLODEXTRINS; ETHERS; EXCIPIENTS; HYDROGEN-ION CONCENTRATION; INDAZOLES; INTESTINAL ABSORPTION; NEUROPROTECTIVE AGENTS; PHOTOCHEMISTRY; POLYVINYL CHLORIDE; SOLUBILITY;

EID: 0035965507     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(01)00851-1     Document Type: Article

References (19)

1. Cyclodextrin derivatives in pharmaceutics
2. The Pharmacokinetics of β-cyclodextrin and hydroxypropyl β-cyclodextrin in the rats
3. Inhibition of neuronal nitric oxide synthase activity by 3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5, 6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate (DY-9760e), a novel neuroprotective agent. In vitro and in cultured neuroblastoma cells in situ
4. Induced circular dichroism of cycloamylose complexes with meta- and para-disubstituted benzenes
5. The circular dichroism spectra of the β-cyclodextrin complex with naphthalene derivatives
6. Phase-solubility techniques
7. Binding specificity between small organic solutes in aqueous solution: Classification of some solutes into two groups according to binding tendencies
8. Pharmaceutical applications of cyclodextrins 1. Drug solubilization and stabilization
9. Pharmacological role of hydroxypropyl-β-cyclodextrins
10. Cyclodextrin inclusion compounds in research and industry
11. DY-9760e, a novel calmodulin antagonist, reduces brain damage induced by transient focal cerebral ischemia
12. Some comments on Benesi-Hildebrand equation
13. Cyclodextrins: Their future in drug formulation and delivery
14. Itraconazole in cyclodextrin solution
15. DY-9760e, a novel calmodulin antagonist with cytoprotective action
16. Highly soluble cyclodextrin derivatives: Chemistry, properties, and trends in development
17. Cyclodextrin-enabling excipients: Their present and future use in pharmaceuticals
18. Cyclodextrin drug carrier system